Willow Biosciences Inc. (3D7.F)

0.0630 -0.0025 (-3.82%) At close: 08:07AM CEST

Willow Biosciences Inc.

202, 1201-5th Street SW
Calgary, AB T2R 0Y6
Canada
403 910 5140
https://www.willowbio.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 19

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Chris Savile	President, Director & CEO	333.72k	N/A	N/A
Mr. Travis Doupe	Chief Financial Officer	256.45k	N/A	1972
Dr. Trish Choudhary	Senior Vice President of Research & Development	228.89k	N/A	N/A
Mr. Troy T. Talkkari	Vice President of Corporate Development	142.43k	N/A	N/A
Mr. Sanjib Singh Gill L.L.B.	Corporate Secretary	N/A	N/A	1976

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.

Corporate governance

Willow Biosciences Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.